Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
3.510
-0.270 (-7.14%)
At close: Apr 3, 2025, 4:00 PM
3.476
-0.034 (-0.98%)
After-hours: Apr 3, 2025, 7:55 PM EDT

Amylyx Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-301.7449.27-198.38-87.93-42.28
Upgrade
Depreciation & Amortization
0.91.090.490.050
Upgrade
Asset Writedown & Restructuring Costs
0.96----
Upgrade
Loss (Gain) From Sale of Investments
-9.86-9.94-2.060.12-
Upgrade
Stock-Based Compensation
33.0437.1621.713.140.24
Upgrade
Other Operating Activities
154.88--5.232.74
Upgrade
Change in Accounts Receivable
39.6-24.74-15.31--
Upgrade
Change in Inventory
-9.25-73.13-9.77--
Upgrade
Change in Accounts Payable
-19.115.881.850.671.42
Upgrade
Change in Other Net Operating Assets
-57.0816.3321.583.931.18
Upgrade
Operating Cash Flow
-167.6511.92-179.87-74.8-36.7
Upgrade
Capital Expenditures
-36.36-1.24-2.53-0.35-0.15
Upgrade
Investment in Securities
112.0193.29-236.46-46.05-
Upgrade
Investing Cash Flow
75.6592.05-238.99-46.41-0.15
Upgrade
Long-Term Debt Issued
---26.1616.82
Upgrade
Long-Term Debt Repaid
----0.26-
Upgrade
Net Debt Issued (Repaid)
---25.916.82
Upgrade
Issuance of Common Stock
2.136.99434.640.340.05
Upgrade
Repurchase of Common Stock
-1.78-3.32---
Upgrade
Other Financing Activities
--0.14-2.85-2.73-
Upgrade
Financing Cash Flow
0.353.54431.79158.5146.82
Upgrade
Foreign Exchange Rate Adjustments
-0.440.16-0.070.01-
Upgrade
Net Cash Flow
-92.08107.6812.8737.319.98
Upgrade
Free Cash Flow
-204.0110.68-182.4-75.15-36.85
Upgrade
Free Cash Flow Margin
-233.50%2.80%-820.50%-26369.12%-5668.92%
Upgrade
Free Cash Flow Per Share
-2.990.15-3.12-11.41-6.06
Upgrade
Cash Income Tax Paid
0.716.390.03--
Upgrade
Levered Free Cash Flow
-157.3738.36-105.35-46.85-23.54
Upgrade
Unlevered Free Cash Flow
-157.3738.36-105.35-46.85-22.11
Upgrade
Change in Net Working Capital
-27.4822.9-0.82-2-2.17
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q